Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Change in Cash (2017 - 2025)

Historic Change in Cash for Inspire Medical Systems (INSP) over the last 9 years, with Q4 2025 value amounting to -$8.0 million.

  • Inspire Medical Systems' Change in Cash fell 40447.31% to -$8.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$45.3 million, marking a year-over-year decrease of 2811.77%. This contributed to the annual value of -$45.3 million for FY2025, which is 2811.77% down from last year.
  • As of Q4 2025, Inspire Medical Systems' Change in Cash stood at -$8.0 million, which was down 40447.31% from $5.9 million recorded in Q3 2025.
  • In the past 5 years, Inspire Medical Systems' Change in Cash registered a high of $231.2 million during Q3 2022, and its lowest value of -$144.4 million during Q4 2023.
  • Moreover, its 5-year median value for Change in Cash was -$2.6 million (2021), whereas its average is -$4.3 million.
  • In the last 5 years, Inspire Medical Systems' Change in Cash soared by 58700.2% in 2022 and then tumbled by 197425.93% in 2024.
  • Quarter analysis of 5 years shows Inspire Medical Systems' Change in Cash stood at $4.3 million in 2021, then skyrocketed by 457.39% to $23.8 million in 2022, then tumbled by 706.96% to -$144.4 million in 2023, then surged by 101.83% to $2.6 million in 2024, then crashed by 404.47% to -$8.0 million in 2025.
  • Its Change in Cash stands at -$8.0 million for Q4 2025, versus $5.9 million for Q3 2025 and $53.0 million for Q2 2025.